C2C BOOKS Logo
3D F&B cover

André Wencker & Pascal Orliac

Solving the us drug conundrum

$9.99

WHY THE U.S. HAS THE HIGHEST PRESCRIPTION DRUG PRICES IN THE WORLD, AND WHAT CAN BE DONE ABOUT IT

Living in one of the richest countries on earth and despite their high level of healthcare
spending, more and more Americans struggle to access their needed medicines, cutting doses
or outright forgoing care, with terrible consequences. While Big Pharma is often cited as the
great culprit, PBMs have more recently come under the spotlight. Our inquiry sets the record
straight and details the consequences. And what is not so usual, we finally offer hope with
actionable solutions.

Published: November 2024

326 pages

$9.99

About the ebook

Why is healthcare so expensive in America? Uncover the truth.

Key Benefits

Different kinds of readers will gain from reading this book

1.

Every US Patients

Every US patient is trying to navigate the terrible US healthcare maze and is willing to learn possible actionable solutions to deeply lower drug prices.

2.

US Employers and Health Benefits Professionals

The book provides them with a detailed view of how the major PBMs are misleading them into catastrophic agreements. Our “Guide to Outsmarting PBMs and Big Pharma ” provides helpful advice on identifying and countering many of these actors’ maneuvers.

3.

Lawmakers

Solving the U.S. Drug Conundrum” is more than another book lamenting the dire situations U.S. patients are in. Combining workable, effective solutions that some local U.S. governments have adopted, we show a way out of the US drug conundrum. Should it extend applying these solutions, America could reconnect with its glorious past as a leader in the fight for progress and social justice. 

" Big Pharma and PBMs are said to be engaged in a fierce battle that will benefit the consumer. What if the public was actually watching one of those bad wrestling matches where each side is careful never to hurt the other? Read Part One to learn more. "
" The FTC and the major PBMs are fighting a legal battle over insulin prices. Who is best positioned? To better understand what is at stake, see Part Two of our book, The US-Specific Insulin Tragedy. "
" The IRA Maximum Fair Price for the first ten medicines is out; how do these prices stay relative to European countries? In part two, we provide relevant data and suggest technical solutions for the US administration to negotiate better, as do almost all developed countries, even the smallest of them! "
" IRA only applies to a small number of drugs and is confined to Medicare. In Part Four, we design solutions that could be effective for a much larger number of drugs, for more people, with significant price reductions. "
" What if states combined solutions that are still on the table, designing an effective solution that will bring prices to levels comparable to those in most other developed countries? "

About

What's in these 300 pages?

The book dissects and explains the mechanics of how Big Pharma and the PBMs operate and their deep-seated complicity in extracting the maximum amount of money at the expense of the American public.

This book reads like a thriller as it delves into some of the most harmful consequences of drug prices, such as what we call the US-specific insulin tragedy, the huge money embezzlement the 340B program has become, and the persistent harmful drug shortages in the face of political inaction and real security problems – that only the Pentagon takes seriously when it comes to the health of its military personnel.

Add to Cart

About the authors

The authors

André Wencker

André, co-founder and CEO of Care2care International LLC, is dedicated to helping Americans get high-quality, affordable pharmacy benefits.

His educational background includes an MS degree from HEC Paris and an Executive Public Health MBA.

He was a certified member of the French Institute of Actuaries. A specialist in health and retirement insurance, he held managerial and executive positions in several French companies: a state-owned healthcare and retirement company, a broker, and mutual insurers. For seven years, André volunteered as a treasurer for the French foundation FORCE, which is dedicated to financing health research.

André WENCKER

Co-founder, Chief Executive Officer
Contact Me

Pascal Orliac

Pascal is the co-founder and chief marketing officer of Care2care International LLC, assisting Americans in getting high-quality, affordable pharmacy benefits.

Pascal held worldwide HR executive positions in a large equipment manufacturing group in the USA and Europe and has been a Lecturer in management at the University of New Hampshire’s Paul College of Business and Economics for many years. Pascal holds an MBA from HEC Paris.

Pascal ORLIAC

Co-founder, Chief Marketing Officer
Contact Me

News and Legislation

Blog

Linkedin